Optinose Stock Fundamentals
| OPTN Stock | USD 1.22 0.10 8.93% |
OptiNose fundamentals help investors to digest information that contributes to OptiNose's financial success or failures. It also enables traders to predict the movement of OptiNose Stock. The fundamental analysis module provides a way to measure OptiNose's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to OptiNose stock.
At this time, OptiNose's Non Operating Income Net Other is very stable compared to the past year. OptiNose | Select Account or Indicator |
OptiNose Company Return On Equity Analysis
OptiNose's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current OptiNose Return On Equity | -10.5 |
Most of OptiNose's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OptiNose is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
OptiNose Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, OptiNose has a Return On Equity of -10.505. This is 56.17% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
OptiNose Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining OptiNose's current stock value. Our valuation model uses many indicators to compare OptiNose value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OptiNose competition to find correlations between indicators driving OptiNose's intrinsic value. More Info.OptiNose is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . At this time, OptiNose's Return On Equity is very stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value OptiNose by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for OptiNose's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the OptiNose's earnings, one of the primary drivers of an investment's value.OptiNose Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OptiNose's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of OptiNose could also be used in its relative valuation, which is a method of valuing OptiNose by comparing valuation metrics of similar companies.OptiNose is currently under evaluation in return on equity category among related companies.
OptiNose Current Valuation Drivers
We derive many important indicators used in calculating different scores of OptiNose from analyzing OptiNose's financial statements. These drivers represent accounts that assess OptiNose's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of OptiNose's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 386.1M | 199.9M | 92.1M | 158.9M | 144.6M | 225.7M | |
| Enterprise Value | 313.5M | 180.9M | 112.3M | 195.8M | 202.6M | 133.5M |
OptiNose Fundamentals
| Return On Equity | -10.5 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.50) % | ||||
| Operating Margin | (0.13) % | ||||
| Current Valuation | 175.22 M | ||||
| Shares Outstanding | 113.04 M | ||||
| Shares Owned By Insiders | 8.93 % | ||||
| Shares Owned By Institutions | 76.28 % | ||||
| Number Of Shares Shorted | 5.92 M | ||||
| Price To Earning | (3.41) X | ||||
| Price To Book | 24.26 X | ||||
| Price To Sales | 1.94 X | ||||
| Revenue | 70.99 M | ||||
| Gross Profit | 67.01 M | ||||
| EBITDA | (22.35 M) | ||||
| Net Income | (35.48 M) | ||||
| Cash And Equivalents | 78.26 M | ||||
| Cash Per Share | 0.94 X | ||||
| Total Debt | 130.23 M | ||||
| Current Ratio | 2.14 X | ||||
| Book Value Per Share | (0.77) X | ||||
| Cash Flow From Operations | (20.53 M) | ||||
| Short Ratio | 3.35 X | ||||
| Earnings Per Share | (0.32) X | ||||
| Price To Earnings To Growth | (0.06) X | ||||
| Target Price | 3.75 | ||||
| Number Of Employees | 132 | ||||
| Beta | -0.1 | ||||
| Market Capitalization | 126.6 M | ||||
| Total Asset | 107.73 M | ||||
| Retained Earnings | (720.38 M) | ||||
| Working Capital | (71.19 M) | ||||
| Current Asset | 83.03 M | ||||
| Current Liabilities | 12.11 M | ||||
| Net Asset | 107.73 M |
About OptiNose Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OptiNose's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OptiNose using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OptiNose based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 184 K | 141.9 K | |
| Total Revenue | 71 M | 44.1 M | |
| Cost Of Revenue | 9 M | 8.2 M | |
| Stock Based Compensation To Revenue | 0.07 | 0.07 | |
| Sales General And Administrative To Revenue | 12.18 | 10.82 | |
| Research And Ddevelopement To Revenue | 0.07 | 0.07 | |
| Capex To Revenue | (0) | (0) | |
| Revenue Per Share | 0.63 | 0.66 | |
| Ebit Per Revenue | (0.32) | (0.34) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out OptiNose Piotroski F Score and OptiNose Altman Z Score analysis. To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for OptiNose Stock analysis
When running OptiNose's price analysis, check to measure OptiNose's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OptiNose is operating at the current time. Most of OptiNose's value examination focuses on studying past and present price action to predict the probability of OptiNose's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OptiNose's price. Additionally, you may evaluate how the addition of OptiNose to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is OptiNose's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OptiNose. If investors know OptiNose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OptiNose listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.32) | Revenue Per Share 0.633 | Quarterly Revenue Growth (0.05) | Return On Assets (0.11) | Return On Equity (10.51) |
The market value of OptiNose is measured differently than its book value, which is the value of OptiNose that is recorded on the company's balance sheet. Investors also form their own opinion of OptiNose's value that differs from its market value or its book value, called intrinsic value, which is OptiNose's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OptiNose's market value can be influenced by many factors that don't directly affect OptiNose's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OptiNose's value and its price as these two are different measures arrived at by different means. Investors typically determine if OptiNose is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OptiNose's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.